Purpose: We aimed to determine appropriate antigen concentrations and the right time to evaluate intranasal changes when performing a nasal provocation test (NPT). Also, we sought to analyze the diagnostic usefulness of individual nasal symptom and peak nasal inspiratory flow (PNIF).
Materials and methods: We divided 46 patients into allergic rhinitis (AR) group (n=19) and a non-allergic rhinitis (NAR) group (n=27). We performed intranasal challenge with 100 AU/mL of Dermatophagoides pteronyssinus (DP) and measured changes in nasal symptoms [scored using the visual analogue scale (VAS)] and PNIF%. If the patient showed significant changes, VAS and PNIF were assessed again after another 15 minutes. In patients without significant changes, we administered 1000 AU/mL and measured changes in nasal symptoms and PNIF% after 15 and 30 minutes.
Results: Fifteen minutes after the 100 AU/mL challenge, the AR group showed more significant VAS changes in all nasal symptoms, total nasal symptom score (TNSS), and PNIF% change than the NAR group. Among the AR group, patients who did not respond to 100 AU/mL exhibited less significant differences relative to the NAR group, even after 1000 AU/mL challenge.
Receiver operating characteristic curve analysis for VAS changes 15 minutes after 100 AU/mL challenge revealed that all nasal symptoms had area under the curve (AUC) values of ≥0.84 (p<0.001). TNSS change had an AUC value of 0.929 (p<0.001), while PNIF% change had an AUC value of 0.834.
Conclusion: We could determine the optimal concentration (100 AU/mL), timing (15 minutes after challenge), and parameters (changes in TNSS and PNIF%) when performing NPT.
Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs
Background Antigen-detecting rapid diagnostic tests (Ag-RDT) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) offer new opportunities for the quick and laboratory-independent identification of infected individuals for control of the SARS-CoV-2 pandemic. Despite the potential benefits, nasopharyngeal sample collection is frequently perceived as uncomfortable by patients and requires trained healthcare personnel with protective equipment. Therefore, anterior nasal self-sampling is increasingly recognized as a valuable alternative.
Methods We performed a prospective, single-center, point of care validation of an Ag-RDT using a polypropylene absorbent collector for standardized self-collected anterior nasal swabs. Real-time polymerase chain reaction (RT-PCR) from combined oropharyngeal/nasopharyngeal swabs served as a comparator. Primary endpoint was sensitivity of the standardized Ag-RDT in symptomatic patients with medium or high viral concentration (≥1 million RNA copies on RT-PCR for SARS-CoV-2).
Results Between 12 February and 22 March 2021, 388 participants were enrolled. After exclusion of 9 patients for which no PCR result could be obtained, the novel Ag-RDT was evaluated based on 379 participants, of whom 273 were symptomatic and 106 asymptomatic.
In 61 samples from symptomatic patients with medium or high viral load (≥1 million RNA copies), the sensitivity of the standardized Ag-RDT was 96.7% (59/61; 95% confidence interval (CI): 88.7-99.6%) for the primary endpoint. In total, 62 positive Ag-RDT results were detected out of 70 RT-PCR positive individuals, yielding an overall sensitivity of 88.6% (95% CI: 78.7-94.9%). Specificity was 99.7% (95% CI: 98.2-100%) in 309 RT-PCR negative individuals.
Conclusions Here, we present a validation of a Roche Antigen Nasal Test Ag-RDT with a standardized sampling process for anterior nasal self-collection, which meets World Health Organisation (WHO) criteria of ≥80% sensitivity and ≥97% specificity. Although less sensitive than RT-PCR, this assay could be beneficial due to its rapid results, ease of use, and suitability for standardized self-testing.
test product |
|||
22332 | National Diagnostics | 2 | 2.76 EUR |
new product test |
|||
23432342 | National Diagnostics | 2 | 2.4 EUR |
Test productt 2 |
|||
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa | National Diagnostics | 0 | Ask for price |
Diogenes Kit |
|||
NAT1000 | National Diagnostics | 1KIT | 270 EUR |
Hydrogen Peroxide Assay Kit |
|||
NAT1002 | National Diagnostics | 1KIT | 308.4 EUR |
ProtoBlock System |
|||
NAT1004 | National Diagnostics | 1KIT | 122.4 EUR |
450ML PBS 10X |
|||
NAT1006 | National Diagnostics | 450ML | 96 EUR |
4L PBS 10X |
|||
NAT1008 | National Diagnostics | 4L | 238.8 EUR |
ProtoGlow ECL 200ml Kit |
|||
NAT1010 | National Diagnostics | EACH | 354 EUR |
ProtoGlow ECL 500ml Kit |
|||
NAT1012 | National Diagnostics | EACH | 627.6 EUR |
100G Acrylamide |
|||
NAT1014 | National Diagnostics | 100G | 120 EUR |
500G Acrylamide |
|||
NAT1016 | National Diagnostics | 500G | 261.6 EUR |
1KG Acrylamide |
|||
NAT1018 | National Diagnostics | 1KG | 412.8 EUR |
25G AquaPor LE |
|||
NAT1020 | National Diagnostics | 25G | 132 EUR |
100G AquaPor LE GTAC |
|||
NAT1022 | National Diagnostics | 100G | 250.8 EUR |
500G AquaPor LE GTAC |
|||
NAT1024 | National Diagnostics | 500G | 878.4 EUR |
25G AquaPor ES |
|||
NAT1026 | National Diagnostics | 25G | 152.4 EUR |
100G AquaPor ES |
|||
NAT1028 | National Diagnostics | 100G | 350.4 EUR |
25G AquaPor LM |
|||
NAT1030 | National Diagnostics | 25G | 288 EUR |
100G AquaPor LM |
|||
NAT1032 | National Diagnostics | 100G | 860.4 EUR |
25G AquaPor HR |
|||
NAT1034 | National Diagnostics | 25G | 236.4 EUR |
100G AquaPor HR |
|||
NAT1036 | National Diagnostics | 100G | 592.8 EUR |
25G AquaPor 3:1 |
|||
NAT1038 | National Diagnostics | 25G | 250.8 EUR |
100G AquaPor 3:1 |
|||
NAT1040 | National Diagnostics | 100G | 570 EUR |
25G Bis (Methylene Bis-Acrylamide) |
|||
NAT1042 | National Diagnostics | 25G | 100.8 EUR |
25G DATD Ultrapure |
|||
NAT1044 | National Diagnostics | 25G | 168 EUR |
250G Glycine |
|||
NAT1046 | National Diagnostics | 250G | 94.8 EUR |
1KG Glycine Ultrapure |
|||
NAT1048 | National Diagnostics | 1KG | 128.4 EUR |
250G Tris |
|||
NAT1050 | National Diagnostics | 250G | 102 EUR |
1KG Tris Ultrapure |
|||
NAT1052 | National Diagnostics | 1KG | 177.6 EUR |
100G Tricine |
|||
NAT1054 | National Diagnostics | 100G | 120 EUR |
100G Ion Exchange Resin (mixed bed) |
|||
NAT1056 | National Diagnostics | 100G | 96 EUR |
25G Riboflavin |
|||
NAT1058 | National Diagnostics | 25G | 96 EUR |
25ML TEMED |
|||
NAT1060 | National Diagnostics | 25ML | 99.6 EUR |
25G Ammonium Persulfate |
|||
NAT1062 | National Diagnostics | 25G | 96 EUR |